Ambu A/S (AMBBY) Stock

About Ambu A/S

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.

Ambu A/S is headquartered in DK.

Ambu A/S (AMBBY) stock trades at $10.86 with a market capitalization of $2.89B. The stock is valued at a price-to-earnings (P/E) ratio of 41.15, price-to-book of 3.20, price-to-sales of 3.19. Over the past 52 weeks the stock has ranged between $8.55 and $16.78, and currently trades 35.3% below its 52-week high. It pays a dividend yielding 0.55%.

On profitability, Ambu A/S generates a return on equity (ROE) of 7.92%, return on capital employed of 9.95%, an operating margin of 10.71%, a net profit margin of 7.81%.

Official website: www.ambu.com